Edity Therapeutics

Using Human Immune Cells to Deliver Therapeutic Proteins

Active A Startup Rehovot Founded 2019-10

Website ↗ LinkedIn

Edity is developing an exciting new platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to reprogram cells and tissue back to health. The technology creates the opportunity to change the course of disease at the intracellular level via multiple mechanisms including protein replacement, target mod…